What is HPGC Renmintongtai Pharmaceutical Corporation's (600829.SS) StockRank?

MoatMap's StockRank for HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) is 46/100, with a Hold signal. This is a composite score combining Quality (52), Value (45), and Momentum (40) factor ranks across MoatMap's 19,000+ stock universe.

Does HPGC Renmintongtai Pharmaceutical Corporation have an economic moat?

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) has a Quality factor score of 52/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is HPGC Renmintongtai Pharmaceutical Corporation a buy, hold, or sell?

MoatMap's current signal for HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) is Hold, based on a StockRank of 46/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is HPGC Renmintongtai Pharmaceutical Corporation in?

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

600829.SS

HOLDREMOVE

HPGC Renmintongtai Pharmaceutical Corporation · Healthcare · China · $746M · Avg Vol: $7M/d

StockRank

P/E (TTM)

35.3x

ROE

4.6%

D/E

0.2x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

HPGC Renmintongtai is a pharmaceutical distributor with low operating margins and high working capital requirements, failing our asset-light quality filter and showing no alignment with our core macro themes.

COMPANY DESCRIPTION

HPGC Renmintongtai Pharmaceutical Corporation distributes pharmaceuticals and operates retail pharmacies in northeastern China. The company holds a dominant pharmaceutical distribution position in Heilongjiang Province with a highly integrated wholesale-retail network. It is a regional healthcare logistics leader backed by Harbin Pharmaceutical Group.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	1.4B	1.5B	1.5B	1.5B	2.5%
EPS	0.07	0.07	0.05	0.03	-20.3%
Shares	580M	580M	580M	580M	0.0%
Debt	187M	151M	133M	108M	-16.7%
Equity	363M	407M	426M	446M	7.0%
Op CF	45M	49M	17M	44M	-0.8%
Inv CF	-867,374	-27M	-1M	-3M	—
Fin CF	22M	17M	-48M	-17M	—

PRICE (1M)-14.5%

SMA 50SMA 200

$1.24

RSI (14)

43.6

52W High

$2.68

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

6.8%62.6

ROE

4.6%55.0

GP/Assets

12.1%29.9

Op. Margin

2.6%50.1

FCF/Assets

3.8%65.2

Piotroski

—83.5

Int. Cover

8.7x62.3

D/E Ratio

0.25x47.4

Current Ratio

1.66x29.0

Value

P/E (TTM)

35.3x30.8

EV/EBITDA

19.2x20.0

P/FCF

125.5x61.8

P/B

1.6x63.7

P/S

0.5x93.4

Div Yield

—N/A

Momentum

52W High %

46%20.1

RS 6M

-43%26.7

SMA 50/200

0.93x42.4

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—82.4

Q Growth

6%46.5

FUNDAMENTALS

Market Cap

$746M

P/E (Forward)

14.1x

Gross Margin

8.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 600829.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
600829.SS	HPGC Renmintongtai Pharmaceutical Corporation(you)	$746M	46	HOLD
688117.SS	ChengDu ShengNuo Biotec Co.,Ltd.	$785M	48	HOLD
300194.SZ	Fuan Pharmaceutical (Group) Co., Ltd.	$672M	43	HOLD
600488.SS	Tianjin Tianyao Pharmaceuticals Co., Ltd.	$894M	40	HOLD
688799.SS	Hunan Warrant Pharmaceutical Co.,Ltd	$975M	50	HOLD
000813.SZ	Dezhan Healthcare Company Limited	$1.0B	42	HOLD
002688.SZ	Jinhe Biotechnology CO., LTD.	$628M	39	HOLD
300158.SZ	Shanxi Zhendong Pharmaceutical Co.,Ltd	$738M	34	SELL
600789.SS	Shandong Lukang Pharmaceutical Co.,Ltd.	$1.2B	48	HOLD
301393.SZ	Suzhou Highfine Biotech Co., Ltd.	$896M	55	HOLD

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.1%

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) — Stock Score Summary

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) has a MoatMap StockRank of 46/100 based on Quality (52/100), Value (45/100), and Momentum (40/100) factor scores. The current signal is HOLD. HPGC Renmintongtai is a pharmaceutical distributor with low operating margins and high working capital requirements, failing our asset-light quality filter and showing no alignment with our core macro themes.

Key Financial Metrics

Price	$1.24
Market Cap	$746M
P/E (TTM)	35.33
P/E (Forward)	14.13
Price/Book	1.61
Return on Equity	4.6%
Return on Invested Capital	6.8%
Debt/Equity	24.65
Gross Margin	8.2%
Operating Margin	2.6%
Revenue Growth	5.9%
Free Cash Flow	$6M

HPGC Renmintongtai Pharmaceutical Corporation operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is HPGC Renmintongtai Pharmaceutical Corporation’s (600829.SS) StockRank?: MoatMap’s StockRank for HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) is 46/100, with a Hold signal. It is a composite of Quality (52), Value (45), and Momentum (40) factor ranks across MoatMap’s 19,000+ stock universe.
Does HPGC Renmintongtai Pharmaceutical Corporation have an economic moat?: HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) has a Quality factor score of 52/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is HPGC Renmintongtai Pharmaceutical Corporation a buy, hold, or sell?: MoatMap’s current signal for HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) is Hold, based on a StockRank of 46/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is HPGC Renmintongtai Pharmaceutical Corporation in?: HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).